Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
27.62 USD | +4.68% | -0.65% | +170.26% |
09/05 | Cullinan Therapeutics Insider Sold Shares Worth $1,796,676, According to a Recent SEC Filing | MT |
29/04 | Cullinan Therapeutics Appoints Mary Kay Fenton as CFO | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+170.26% | 113.61Cr | |
+28.41% | 4.92TCr | |
+0.78% | 4.21TCr | |
+50.47% | 4.04TCr | |
-5.26% | 2.89TCr | |
+13.87% | 2.61TCr | |
-22.34% | 1.87TCr | |
+7.93% | 1.33TCr | |
+32.49% | 1.23TCr | |
-0.45% | 1.2TCr |
- Stock Market
- Equities
- CGEM Stock
- News Cullinan Therapeutics, Inc.
- Cullinan Oncology : Morgan Stanley Upgrades Cullinan Management to Overweight from Equalweight, Sets $40 Price Target